Latest Esophagectomy Stories
Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery.
SUNNYVALE, Calif., March 10, 2011 /PRNewswire/ -- BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association (AGA) has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.
Endoscopic removal of pre-cancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended rather than surveillance.
Esophagectomy is a standard treatment for resectable esophageal carcinoma but relatively few patients are cured.
Researchers at the Mayo Clinic have found that early stage cancers of the esophagus can be treated effectively by organ-sparing endoscopic therapy, thereby avoiding the surgical removal of the esophagus.
Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat.
New research from Trinity College Dublin published in this monthâ€™s Annals of Surgery points to a potentially significant advance in the treatment of patients undergoing major cancer surgery.
SUNNYVALE, Calif., Oct. 19 /PRNewswire/ -- BARRX Medical, Inc. today announced clinical trial results presented at the United European Gastroenterology Week (UEGW) in Vienna, Austria, October 18-22, 2008.